Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease (CKD) Undergoing Percutaneous Coronary Intervention with a Drug Eluting Stent: A Meta-Analysis.
Maria Carolina FestaSathiepan RasasingamAbhinav SharmaThomas A MavrakanasPublished in: Kidney360 (2023)
P2Y12 inhibitor monotherapy after a shortened course of DAPT appears to be associated with a similar risk of ischemic events and a lower risk of bleeding events after DES insertion among patients with CKD compared to 12-month DAPT.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- chronic kidney disease
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- coronary artery disease
- coronary artery bypass grafting
- coronary artery bypass
- type diabetes
- combination therapy
- clinical trial
- heart failure
- cerebral ischemia
- blood brain barrier
- brain injury